Are Artemis Medicare latest results good or bad?

Artemis Medicare Services has reported its financial results for the quarter ending June 2025, highlighting several key operational metrics. The company achieved a Profit After Tax (PAT) of Rs 44.31 crore, reflecting a year-on-year growth of 43.63%, which suggests a strong near-term outlook. The Operating Profit to Interest ratio improved to 5.61 times, marking the highest level in the last five quarters, indicating enhanced management of interest obligations.
Net sales reached Rs 254.96 crore, the highest in the last five quarters, and the Profit Before Tax (PBT) was reported at Rs 22.85 crore, showing a growth of 22.4% compared to the average of the previous four quarters. Additionally, the company has reduced its Debt-Equity Ratio to 0.35 times, the lowest in five half-yearly periods, and increased its annual Dividend per Share (DPS) to Rs 0.45, the highest in five years.

However, on a quarter-on-quarter basis, there was a reported decline in consolidated net profit of 7.60% compared to the previous quarter, alongside a net sales growth of 6.28%. The Operating Profit margin (excluding other income) showed a slight increase to 16.24%.

Overall, the financial data indicates that while Artemis Medicare has made significant strides in certain areas, there are mixed results when comparing the latest quarter to the previous one. The company saw an adjustment in its evaluation based on these results.